A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 127,000 shares of ATNM stock, worth $157,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,000
Previous 19,200 561.46%
Holding current value
$157,480
Previous $142,000 67.61%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.72 - $8.0 $185,416 - $862,400
107,800 Added 561.46%
127,000 $238,000
Q2 2024

Aug 09, 2024

BUY
$6.56 - $9.89 $125,951 - $189,888
19,200 New
19,200 $142,000
Q2 2023

Aug 11, 2023

SELL
$7.15 - $9.39 $385,370 - $506,102
-53,898 Reduced 52.74%
48,302 $358,000
Q1 2023

May 12, 2023

SELL
$8.51 - $14.26 $488,474 - $818,524
-57,400 Reduced 35.96%
102,200 $966,000
Q4 2022

Feb 13, 2023

BUY
$7.05 - $14.41 $573,165 - $1.17 Million
81,300 Added 103.83%
159,600 $1.7 Million
Q3 2022

Nov 14, 2022

BUY
$4.81 - $8.48 $99,085 - $174,688
20,600 Added 35.7%
78,300 $578,000
Q2 2022

Aug 12, 2022

BUY
$4.71 - $7.11 $271,767 - $410,247
57,700 New
57,700 $278,000

Others Institutions Holding ATNM

About Actinium Pharmaceuticals, Inc.


  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $31.2M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.